1. Combinational strategies of metformin and chemotherapy in cancers
   Hui-Hui Zhang et al, 2016, Cancer Chemother Pharmacol CrossRef
2. Turmeric: A Review of Its Chemical Composition, Quality Control, Bioactivity, and Pharmaceutical Application
   Fan-Cheng Meng et al, 2018 CrossRef
3. Metformin prevents nerve growth factor-dependent proliferative and proangiogenic effects in epithelial ovarian cancer cells and endothelial cells
   Maritza P. Garrido et al, 2018, Ther Adv Med Oncol CrossRef
4. Combination of metformin with chemotherapeutic drugs via different molecular mechanisms
   Mei Peng et al, 2017, Cancer Treatment Reviews CrossRef
5. The Emerging Role of TYRO3 as a Therapeutic Target in Cancer
   Sherri Smart et al, 2018, Cancers CrossRef
6. TYRO3: A potential therapeutic target in cancer
   Pei-Ling Hsu et al, 2019, Exp Biol Med (Maywood) CrossRef
7. Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity
   Stanley G. Kimani et al, 2017, Sci Rep CrossRef
8. Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds
   Roberto Würth et al, 2016, Drug Discovery Today CrossRef
9. Antitumoral Effects of Metformin in Ovarian Cancer
   Maritza P. Garrido et al, 2019 CrossRef
10. Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis
    Robert Brenig et al, 2020, Life Sci. Alliance CrossRef
11. TAM family proteins and therapy resistance
    Nellie K. McDaniel et al, 2020 CrossRef
12. TAM receptors Tyro3 and Mer as novel targets in colorectal cancer
    Robin Schmitz et al, 2016, Oncotarget CrossRef
13. Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells
    Seong Hye Park et al, 2016, Oncotarget CrossRef
14. Metformin suppresses the growth of leukemia cells partly through downregulation of AXL receptor tyrosine kinase
    Tatsuya Saito et al, 2020, Leukemia Research CrossRef
15. MUL1 E3 ligase regulates the antitumor effects of metformin in chemoresistant ovarian cancer cells via AKT degradation
    Junwoo Lee et al, 2019, Int J Oncol CrossRef
16. The Multifaceted Roles of TAM Receptors during Viral Infection
    Zhao-Yang Wang et al, 2020, Virol. Sin. CrossRef
17. TAM receptors: A phosphatidylserine receptor family and its implications in viral infections
    Sounak Ghosh Roy, 2020 CrossRef
18. Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells
    Yoo Jin Na et al, 2021, Korean J Intern Med CrossRef
19. Identification of signalling pathways activated by Tyro3 that promote cell survival, proliferation and invasiveness in human cancer cells
    Nour Al Kafri et al, 2021, Biochemistry and Biophysics Reports CrossRef
20. Metformin pretreatment reduces effect to dacarbazine and suppresses melanoma cell resistance
    Larissa J. Sanches et al, 2021, Cell Biol Int CrossRef
21. G-749 Promotes Receptor Tyrosine Kinase TYRO3 Degradation and Induces Apoptosis in Both Colon Cancer Cell Lines and Xenograft Mouse Models
    Hae Dong Kim et al, 2021, Front. Pharmacol. CrossRef
22. A new approach for the pleiotropic effect of metformin use in type 2 diabetes mellitus
    Yasemin Atici et al, 2022 CrossRef
23. AXL Promotes Metformin-Induced Apoptosis Through Mediation of Autophagy by Activating ROS-AMPK-ULK1 Signaling in Human Esophageal Adenocarcinoma
    Jun Hong et al, 2022, Front. Oncol. CrossRef
24. Metformin Improves Ovarian Cancer Sensitivity to Paclitaxel and Platinum-Based Drugs: A Review of In Vitro Findings
    Giovanni Tossetta, 2022, IJMS CrossRef
25. Diabetes and ovarian cancer: risk factors, molecular mechanisms and impact on prognosis
    Farzaneh Karimi et al, 2023, Endocrine CrossRef
26. TAM family kinases as therapeutic targets at the interface of cancer and immunity
    Deborah DeRyckere et al, 2023, Nat Rev Clin Oncol CrossRef
27. Anexelekto (AXL) no more: microRNA-155 (miR-155) controls the “Uncontrolled” in SARS-CoV-2
    K. I. Papadopoulos et al, 2024, Human Cell CrossRef
28. Metformin: A Dual-Role Player in Cancer Treatment and Prevention
    Mariam Ahmed Galal et al, 2024, IJMS CrossRef
29. Recent discovery and development of AXL inhibitors as antitumor agents
    Zihang Liu et al, 2024, European Journal of Medicinal Chemistry CrossRef
30. Antiproliferative Mechanisms of Metformin in Breast Cancer: A Systematic Review of the Literature
    Aiman Moldasheva et al, 2024, IJMS CrossRef